Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018

Joint Authors

Sarras, Michael Peter
Ruano, Rodrigo
Egan, Aoife M.
Enninga, Elizabeth Ann L.
Leontovich, Alexey A.
Alrahmani, Layan

Source

Journal of Diabetes Research

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-11-22

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases
Medicine

Abstract EN

The Center for Disease Control and Prevention ranks diabetes mellitus (DM) as the seventh leading cause of death in the USA.

The most prevalent forms of DM include Type 2 DM, Type 1 DM, and gestational diabetes mellitus (GDM).

While the acute problem of diabetic hyperglycemia can be clinically managed through dietary control and lifestyle changes or pharmacological intervention with oral medications or insulin, long-term complications of the disease are associated with significant morbidity and mortality.

These long-term complications involve nearly all organ systems of the body and share common pathologies associated with endothelial cell abnormalities.

To better understand the molecular mechanisms underlying DM as related to future long-term complications following hyperglycemia, we have undertaken a study to determine the frequency that GDM did or did not occur in the second pregnancy of women who experienced GDM in their first pregnancy between 2013 and 2018 at Mayo Clinic, Rochester, MN.

Within the five-year period of the study, the results indicate that 7,330 women received obstetrical care for pregnancy during the study period.

Of these, 150 developed GDM in their first pregnancy and of these, 42 (28%) had a second pregnancy.

Of these 42 women, 20 again developed GDM and 22 did not develop GDM in their second pregnancy within the study period.

Following the occurrence of GDM in the first pregnancy, the study (1) established the number of women with and without GDM in the second pregnancy and (2) confirmed the feasibility to study diabetic metabolic memory using maternal placental tissue from GDM women.

These studies represent Phase I of a larger research project whose goal is to analyze epigenetic mechanisms underlying true diabetic metabolic memory using endothelial cells isolated from the maternal placenta of women with and without GDM as described in this article.

American Psychological Association (APA)

Enninga, Elizabeth Ann L.& Egan, Aoife M.& Alrahmani, Layan& Leontovich, Alexey A.& Ruano, Rodrigo& Sarras, Michael Peter. 2019. Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018. Journal of Diabetes Research،Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1173462

Modern Language Association (MLA)

Enninga, Elizabeth Ann L.…[et al.]. Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018. Journal of Diabetes Research No. 2019 (2019), pp.1-7.
https://search.emarefa.net/detail/BIM-1173462

American Medical Association (AMA)

Enninga, Elizabeth Ann L.& Egan, Aoife M.& Alrahmani, Layan& Leontovich, Alexey A.& Ruano, Rodrigo& Sarras, Michael Peter. Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018. Journal of Diabetes Research. 2019. Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1173462

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1173462